# An Observational Study Investigating the Treatment Satisfaction of Atopic Dermatitis Patients Who Have Switched to Ointment (W/O Emulsion) Formulation of Very Strong Class Topical Corticosteroids

> **NCT02627989** · — · COMPLETED · sponsor: **LEO Pharma** · enrollment: 55 (actual)

## Conditions studied

- Dermatitis, Atopic

## Interventions

- **DRUG:** Diflucortolone valerate (Nerisona)
- **DRUG:** Diflucortolone valerate (Texmeten)

## Key facts

- **NCT ID:** NCT02627989
- **Lead sponsor:** LEO Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12-10
- **Primary completion:** 2016-11-17
- **Final completion:** 2017-01-17
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2020-04-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02627989

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02627989, "An Observational Study Investigating the Treatment Satisfaction of Atopic Dermatitis Patients Who Have Switched to Ointment (W/O Emulsion) Formulation of Very Strong Class Topical Corticosteroids". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT02627989. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*